E

Elevian, Inc.

17 employees

Elevian develops medicines that restore youthful regenerative capacity with the potential to treat and prevent many age-related diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Biopharma

Date founded

2018

Funding rounds raised

Total raised

$40M

from 15 investors over 15 rounds

E

Elevian, Inc. raised $40M on September 16, 2021

Investors: Prime Movers Lab, Leslie Ventures, Kuelbs Family Office and BOLD Capital Partners

E

Elevian, Inc. raised $15M on November 24, 2020

Investors: For Good Ventures, SAVEarth Fund, The Longevity Fund, KIZOO, Western Technology, BOLD Capital Partners and Lauder Partners, LLC

E

Elevian, Inc. raised undisclosed on March 7, 2019

Investors: Formic Ventures

E

Elevian, Inc. raised $2.9M on February 20, 2018

Investors: BOLD Capital Partners and Thynk Capital

E

Elevian, Inc. raised $2.6M on October 20, 2017

Investors: KIZOO

FAQ